JEAN JACQUES BIENAIME
CIK 1221590 · Chief Executive Officer · last filed 2026-06-10
JEAN JACQUES BIENAIME is a Chief Executive Officer who has filed 440 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for INCY, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$240.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $30.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$30.18M
6
440
-$240.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Director | 24,424 | $108.53 | $2.65M | $320.5K | 45 | 2026-06-10 |
| IMNM | Director | 38,915 | $18.38 | $715.3K | $437.4K | 11 | 2026-06-09 |
| KROS | Director | 16,592 | $10.15 | $168.4K | $44.7K | 6 | 2026-06-05 |
| ASND | Director | 600 | $218.06 | $130.8K | $206.7K | 2 | 2026-06-01 |
| BMRN | Director | 473,892 | $55.95 | $26.51M | -$241.37M | 336 | 2024-05-21 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 1,706 | — | — | $3.9K | 4 | 2014-03-10 |
Recent Filings
440 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | INCY | Grant (A) | +1,642 | $0 | EDGAR |
| 2026-06-09 | IMNM | Mixed | — | $440 | EDGAR |
| 2026-06-05 | KROS | Grant (A) | +7,142 | $0 | EDGAR |
| 2026-06-01 | ASND | Buy (P) | +500 | $111.6K | EDGAR |
| 2026-05-28 | INCY | Mixed | +1,941 | -$79 | EDGAR |
| 2026-05-27 | ASND | Buy (P) | +400 | $95.1K | EDGAR |
| 2026-05-19 | KROS | Buy (P) | +1,000 | $10.6K | EDGAR |
| 2026-05-19 | IMNM | Buy (P) | +5,000 | $103.5K | EDGAR |
| 2026-04-17 | KROS | Buy (P) | +1,000 | $11.7K | EDGAR |
| 2026-03-12 | IMNM | Buy (P) | +2,000 | $43.7K | EDGAR |